Last reviewed · How we verify
Opiates exposure treated with BPN
At a glance
| Generic name | Opiates exposure treated with BPN |
|---|---|
| Also known as | Suboxone, Subutex, Buprenex |
| Sponsor | Gauda, Estelle B., M.D. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder (PHASE3)
- Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Opiates exposure treated with BPN CI brief — competitive landscape report
- Opiates exposure treated with BPN updates RSS · CI watch RSS
- Gauda, Estelle B., M.D. portfolio CI